Quince Therapeutics(QNCX) - 2020 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR (Exact Name of Registrant as Specified in its Charter) Delaware 90-1024039 ( State or other jurisdiction of incorporation or organization) 269 East Grand Ave. South San Francisco, California 94080 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identification ...